Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ -2.59Free Cash Flow per Share
VS
Market
Sector
Industry
History
$ 16.95Close
$ 3.93 - $ 21.42 52-Week Range
Ticker Information
Ticker
URGNCompany Name
UROGEN PHARMA LTDSector
HealthcareIndustry
BiotechnologyExchange
NASDAQUROGEN PHARMA LTD - Free Cash Flow per Share Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
URGN - FCFPS Historical data
| Date | Free Cash Flow | Free Cash Flow per Share | Share Factor | Weighted Average Shares |
|---|---|---|---|---|
| 6/30/2025 | $ -123.53M | $ -2.59 | 1 | 47.74M |
| 3/31/2025 | $ -107.39M | $ -2.26 | 1 | 47.42M |
| 12/31/2024 | $ -97.06M | $ -2.26 | 1 | 42.88M |
| 9/30/2024 | $ -96.38M | $ -2.24 | 1 | 43.1M |
| 6/30/2024 | $ -86.02M | $ -2.34 | 1 | 36.82M |
| 3/31/2024 | $ -82.47M | $ -2.47 | 1 | 33.38M |
| 12/31/2023 | $ -76.57M | $ -2.66 | 1 | 28.83M |
| 9/30/2023 | $ -85.28M | $ -2.64 | 1 | 32.3M |
| 6/30/2023 | $ -85.65M | $ -3.65 | 1 | 23.46M |
| 3/31/2023 | $ -89.62M | $ -3.85 | 1 | 23.28M |
Key Performance Insights, Last 5 Years
- UROGEN PHARMA LTD's latest trailing twelve months (TTM) FCFPS stands at $ -5.07.
- Over the past 5 years, UROGEN PHARMA LTD's average FCFPS has been $ -3.42.
- The median FCFPS for UROGEN PHARMA LTD during this period was $ -3.72
- UROGEN PHARMA LTD reached its highest FCFPS over the past 5 years at $ -2.24.
- The lowest FCFPS recorded by UROGEN PHARMA LTD in the same timeframe $ -5.07
UROGEN PHARMA LTD's FCFPS vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
FCFPS Benchmarks
Similar metrics to Shares WA:
- Operating Cash Flow per Share - [Calculation] The amount of Operating Cash Flow attributed to each share, calculated as [NCFO] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Book Value per Share - [Calculation] The amount of equity attributed to each share, calculated as [Equity] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Sales per Share - [Calculation] The amount of revenue attributed to each share, calculated as [Revenue] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- EBIT per Share - [Calculation] The amount of earnings before interest and taxes attributed to each share, calculated as [EBIT] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- EBITDA per Share - [Calculation] The amount of earnings before interest, taxes, depreciation, and amortization attributed to each share, calculated as [EBITDA] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
Definition of Free Cash Flow per Share
[Calculation] The amount of Free Cash Flow attributed to each share, calculated as [FCF] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].FCF / (Shares WA * Share Factor)
(=) FCFPS FCFPS for UROGEN PHARMA LTD is calculated as follows: FCF [ $ -111.88M ] / (Shares WA [ 22.06M ] * Share Factor [ 1 ])
(=) FCFPS [ $ -5.07 ] URGN - Free Cash Flow per Share, Last 5 years
$ -5.07
Minimum
Sep 30, 2020
$ -2.24
Maximum
Sep 30, 2024
$ -3.42
Average
$ -3.72
Median
FCFPS Benchmark AnalysisMarket
The chart above depicts the distribution of FCFPS for companies in the Total Stock Market. The average FCFPS of the companies is $ 0.8 with a standard deviation of $ 2.82.
The following table provides additional summary stats:
FCFPS in the Market:
| filtered constituents | 3.76K |
|---|---|
| min | $ -7.96 |
| max | $ 8.85 |
| average | $ 0.8 |
| median | $ 0.29 |
| std | $ 2.82 |